Frost & Sullivan Americas

Medicare law triggers business model and procedure changes

Published in Physician Law Weekly, September 8th, 2004

The business models and procedures of pharmaceutical companies are in for broad modifications in response to the new Medicare Prescription Drug Law.

While profits may not skyrocket, the development can certainly give the industry a boost.

New analysis from Frost & Sullivan, "Changing Role of Medicare and its Impact on Pharmaceutical Companies," reveals that the Medicare spending grew at a rate of 5.7% in 2003. It is likely to grow at a CAGR of 9.2% from 2003 to 2010.

Pharmacy benefit managers (PBM) and private insurance providers are likely to be among the first to tackle the effects of the law changes. They have to draw on all...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2004-09-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry